Trial Profile
The Effect of Exercise and Alagebrium on the Diastolic Function of the Heart
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Aug 2020
Price :
$35
*
At a glance
- Drugs Alagebrium chloride (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Acronyms AGE
- 01 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2012 Planned end date changed from 1 Sep 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 12 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.